Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafne Müller

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 26, 2022
Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer ImmunotherapyDafne Müller
Oncoimmunology|November 22, 2012
Targeted cancer immunotherapy: Mimicking physiological trans-presentation of IL-15Dafne Müller
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 11, 2013
Antibody-cytokine fusion proteins for cancer immunotherapy: an update on recent developmentsDafne Müller
Pharmacology & Therapeutics|July 7, 2015
Antibody fusions with immunomodulatory proteins for cancer therapyDafne Müller
Current Opinion in Molecular Therapeutics|August 19, 2007
Recombinant bispecific antibodies for cellular cancer immunotherapyDafne Müller, Roland E Kontermann
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 5, 2010
Bispecific antibodies for cancer immunotherapy: Current perspectivesDafne Müller, Roland E Kontermann
Methods in Molecular Biology (Clifton, N.J.)|September 10, 2018
Production, Purification, and Characterization of Antibody-TNF Superfamily Ligand Fusion ProteinsMartin Siegemund, Nadine Beha, Dafne Müller
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
A novel antibody-4-1BBL fusion protein for targeted costimulation in cancer immunotherapyDafne Müller, Katharina Frey, Roland E Kontermann
Frontiers in Cell and Developmental Biology|July 26, 2023
Mechanosensory feedback loops during chronic inflammationSarbari Saha, Dafne Müller, Andrew G Clark
Protein Engineering, Design & Selection : PEDS|November 6, 2007
A novel tri-functional antibody fusion protein with improved pharmacokinetic properties generated by fusing a bispecific single-chain diabody with an albumin-binding domain from streptococcal protein GRoland Stork, Dafne Müller, Roland E Kontermann
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 26, 2022
Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer ImmunotherapyDafne Müller
Oncoimmunology|November 22, 2012
Targeted cancer immunotherapy: Mimicking physiological trans-presentation of IL-15Dafne Müller
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 11, 2013
Antibody-cytokine fusion proteins for cancer immunotherapy: an update on recent developmentsDafne Müller
Pharmacology & Therapeutics|July 7, 2015
Antibody fusions with immunomodulatory proteins for cancer therapyDafne Müller
Current Opinion in Molecular Therapeutics|August 19, 2007
Recombinant bispecific antibodies for cellular cancer immunotherapyDafne Müller, Roland E Kontermann
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 5, 2010
Bispecific antibodies for cancer immunotherapy: Current perspectivesDafne Müller, Roland E Kontermann
Methods in Molecular Biology (Clifton, N.J.)|September 10, 2018
Production, Purification, and Characterization of Antibody-TNF Superfamily Ligand Fusion ProteinsMartin Siegemund, Nadine Beha, Dafne Müller
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
A novel antibody-4-1BBL fusion protein for targeted costimulation in cancer immunotherapyDafne Müller, Katharina Frey, Roland E Kontermann
Frontiers in Cell and Developmental Biology|July 26, 2023
Mechanosensory feedback loops during chronic inflammationSarbari Saha, Dafne Müller, Andrew G Clark
Protein Engineering, Design & Selection : PEDS|November 6, 2007
A novel tri-functional antibody fusion protein with improved pharmacokinetic properties generated by fusing a bispecific single-chain diabody with an albumin-binding domain from streptococcal protein GRoland Stork, Dafne Müller, Roland E Kontermann
Pageof 4